Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.

Moore BR, Salman S, Benjamin J, Page-Sharp M, Robinson LJ, Waita E, Batty KT, Siba P, Mueller I, Davis TM, Betuela I.

Antimicrob Agents Chemother. 2014;58(1):432-9. doi: 10.1128/AAC.01437-13. Epub 2013 Nov 4.

2.

Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.

Kim YR, Kuh HJ, Kim MY, Kim YS, Chung WC, Kim SI, Kang MW.

Arch Pharm Res. 2004 May;27(5):576-80.

PMID:
15202566
3.

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.

Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S.

Am J Trop Med Hyg. 2008 May;78(5):736-40.

4.

Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.

Batty KT, Salman S, Moore BR, Benjamin J, Lee ST, Page-Sharp M, Pitus N, Ilett KF, Mueller I, Hombhanje FW, Siba P, Davis TM.

Antimicrob Agents Chemother. 2012 May;56(5):2472-84. doi: 10.1128/AAC.06250-11. Epub 2012 Feb 13.

5.

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.

Pukrittayakamee S, Imwong M, Chotivanich K, Singhasivanon P, Day NP, White NJ.

Am J Trop Med Hyg. 2010 Apr;82(4):542-7. doi: 10.4269/ajtmh.2010.09-0428.

6.

Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age.

Betuela I, Bassat Q, Kiniboro B, Robinson LJ, Rosanas-Urgell A, Stanisic D, Siba PM, Alonso PL, Mueller I.

Antimicrob Agents Chemother. 2012 Apr;56(4):2146-9. doi: 10.1128/AAC.05566-11. Epub 2012 Jan 17.

8.

Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.

Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalearmrult K, Mint HY, Maneekan P, White NJ, Gourdeuk VR, Brittenham GM, Looareesuwan S.

Am J Trop Med Hyg. 2003 Jul;69(1):14-8.

9.

Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.

Dao NV, Cuong BT, Ngoa ND, Thuy le TT, The ND, Duy DN, Dai B, Thanh NX, Chavchich M, Rieckmann KH, Edstein MD.

Trans R Soc Trop Med Hyg. 2007 Jun;101(6):534-9. Epub 2007 Mar 21.

PMID:
17368694
10.

Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study.

Benjamin J, Moore B, Lee ST, Senn M, Griffin S, Lautu D, Salman S, Siba P, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2012 May;56(5):2465-71. doi: 10.1128/AAC.06248-11. Epub 2012 Feb 13.

11.

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.

Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, Page-Sharp M, Lin E, Lammey J, Batty KT, Davis TM.

Antimicrob Agents Chemother. 2008 Jan;52(1):237-43. Epub 2007 Oct 29.

12.

Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.

Betuela I, Rosanas-Urgell A, Kiniboro B, Stanisic DI, Samol L, de Lazzari E, Del Portillo HA, Siba P, Alonso PL, Bassat Q, Mueller I.

J Infect Dis. 2012 Dec 1;206(11):1771-80. doi: 10.1093/infdis/jis580. Epub 2012 Sep 10.

13.

Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.

Fryauff DJ, Baird JK, Basri H, Wiady I, Purnomo, Bangs MJ, Subianto B, Harjosuwarno S, Tjitra E, Richie TL, Hoffman SL.

Ann Trop Med Parasitol. 1997 Jan;91(1):7-16.

PMID:
9093424
14.

Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.

Walsh DS, Wilairatana P, Tang DB, Heppner DG Jr, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S.

Clin Infect Dis. 2004 Oct 15;39(8):1095-103. Epub 2004 Sep 24.

15.

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.

John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, Price RN.

Malar J. 2012 Aug 17;11:280. doi: 10.1186/1475-2875-11-280. Review.

16.

Lack of sex effect on the pharmacokinetics of primaquine.

Elmes NJ, Bennett SM, Abdalla H, Carthew TL, Edstein MD.

Am J Trop Med Hyg. 2006 Jun;74(6):951-2.

17.

Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.

Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, Setiabudy R, Nurleila S, Ekawati LL, Elyazar I, Farrar J, Sudoyo H, Baird JK.

Antimicrob Agents Chemother. 2013 Mar;57(3):1128-35. doi: 10.1128/AAC.01879-12. Epub 2012 Dec 17.

18.

Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.

Wilairatana P, Silachamroon U, Krudsood S, Singhasivanon P, Treeprasertsuk S, Bussaratid V, Phumratanaprapin W, Srivilirit S, Looareesuwan S.

Am J Trop Med Hyg. 1999 Dec;61(6):973-7.

20.

[A study of relapsed cases of vivax malaria after the standard primaquine therapy].

Kimura M, Tomizawa I, Takizawa Y, Ohtomo H.

Kansenshogaku Zasshi. 1996 Oct;70(10):1086-91. Japanese.

PMID:
8952270
Items per page

Supplemental Content

Write to the Help Desk